Tradestie Institutional Equity Comparison Engine

EDIT vs TWST โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TWST Overall Edge

TWST Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Twist Bioscience Corporation Common Stock (TWST) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EDIT trades at N/M Forward P/E with -167.0% operating margin (+37.4% YoY revenue) versus TWST at N/M Forward P/E and -31.9% operating margin (+23.2% YoY). In options structure, EDIT sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro) against TWST sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EDIT N/M vs TWST N/M Fwd P/E
Growth & Margin Winner TWST
Op Margin -167.0% vs -31.9% ยท YoY +37.4% vs +23.2%
Momentum & Technical Winner TWST
1Y -25.0% vs +254.0% ยท 52W Pos 11% vs 42%
Options & Structure Winner TWST
BREAKDOWN (38th %ile IV) vs CONSOLIDATION (18th %ile IV)
EDIT NASDAQ
Editas Medicine, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.91
-12.21% 1D
Market Cap $336.5M
1M Return -18.94%
1Y Return -25.0%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 33.0 Fund 55.0 Flow 69.0 Mom 60.0
TWST NASDAQ
Twist Bioscience Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$105.85
-5.15% 1D
Market Cap $7.6B
1M Return -20.26%
1Y Return +254.01%
Forward P/E N/M
Unified AI Score
51.7 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 68.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EDIT -25.0% TWST +254.01% Spread: +279.01 pp (TWST Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EDIT Revenue TWST Revenue EDIT Op. Margin TWST Op. Margin Margin Edge
FY2018 $30M $30M -356.1% -277.5% TWST
FY2019 $20M $50M -686.4% -200.1% TWST
FY2020 $90M $90M -148.6% -155.5% EDIT
FY2021 $30M $130M -756.1% -115.4% TWST
FY2022 $20M $200M -1146.3% -115.3% TWST
FY2023 $80M $250M -216.6% -88.6% TWST
FY2024 $30M $310M -777.2% -70.6% TWST
FY2025 $40M $380M -394.9% -36.2% TWST

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EDIT (2) vs TWST (6)
Institutional Metric EDIT TWST Criterion Row Winner
Market Capitalization Scale $336.5M $7.6B Larger Scale TWST
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +37.4% +23.2% Higher Growth EDIT
Operating Margin (TTM) Profitability -167.0% -31.9% Higher Margin TWST
Net Profit Margin Profitability -144.9% -31.7% Higher Margin TWST
Return on Equity (ROE) Capital Efficiency -147.4% -29.6% Higher ROE TWST
52-Week Range Position Momentum 11% ($2โ€“$4) 42% ($23โ€“$220) Stronger Trend TWST
Beta / 30D Volatility Risk Regime 2.32ฮฒ ยท 102% Vol 3.15ฮฒ ยท 127% Vol Lower Realized Risk EDIT
Unified Institutional Score Composite Signal 48.4 / 100 (HOLD) 51.7 / 100 (HOLD) Higher Composite TWST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EDIT vs TWST Buy Guide
EDIT BREAKDOWN
146d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EDIT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TWST CONSOLIDATION
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live TWST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EDIT nor TWST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.